Synapse - Works

Results (117469)

North American leukemia, intergroup phase III randomized trial of single agent clofarabine as induction and post-remission therapy, and decitabine as maintenance therapy in newly-diagnosed acute myeloid leukemia in older adults (age >= 60 years): A trial of the ECOG-ACRIN Cancer Research Group (E2906)

Meeting Abstract

Foran, J. M.; Sun, Z. X.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D.; Zhang, Y. M.; more...
Blood (2015)

Fulltext@MSK | Save

B-lymphoid transcription factors restrict glycolytic energy supply for oncogenic signaling

Meeting Abstract

Chan, L. N.; Chen, Z. S.; Braas, D.; Geng, H. M.; Hurtz, C.; Shojaee, S.; Cazzaniga, V.; Ng, C.; Ernst, T.; Hochhaus, A.; more...
Blood (2015)

Fulltext@MSK | Save

Alemtuzumab-cyclosporine versus tacrolimus-methotrexate-sirolimus for graft-versus-host disease prophylaxis in reduced intensity allogeneic hematopoietic stem cell transplantation from unrelated donors: Final results of a randomized trial

Meeting Abstract

Curtis, L. M.; Pavletic, S. Z.; Salit, R. B.; Shaffer, B. C.; Steinberg, S. M.; Wilder, J. S.; Pirsl, F.; Blacklock-Schuver, B.; Hsu, J.; Hughes, T. E.; more...
Blood (2015)

Fulltext@MSK | Save

Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): Sub-analysis of SWOG S0816 phase 2 trial

Meeting Abstract

Danilov, A. V.; Li, H. L.; Press, O. W.; Shapira, I.; Swinnen, L. J.; Noy, A.; Reid, E.; Smith, S. M.; Friedberg, J. W.
Blood (2015)

Fulltext@MSK | Save

Molecular profiling and relationship with clinical response in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class potent inhibitor of mutant IDH1, in addition to data from the completed dose escalation portion of the phase 1 study

Meeting Abstract

DiNardo, C.; de Botton, S.; Pollyea, D. A.; Stein, E. M.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I. W.; Altman, J. K.; more...
Blood (2015)

Fulltext@MSK | Save

Risk-adapted therapy in adults with Burkitt lymphoma: Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R

Meeting Abstract

Dunleavy, K.; Noy, A.; Abramson, J. S.; LaCasce, A. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P. J.; Mitsuyasu, R. T.; Battini, R.; more...
Blood (2015)

Fulltext@MSK | Save

Outcomes of inferior vena cava filter placement in a large population of cancer patients diagnosed with pulmonary embolism: Risk for recurrent venous thromboembolism, survival, and filter-related complications

Meeting Abstract

Coombs, C. C.; Kuk, D.; Devlin, S.; Siegelbaum, R.; Parameswaran, R.; Mantha, S.; Soff, G. A.
Blood (2015)

Fulltext@MSK | Save

PD-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Safety, efficacy, and biomarker assessment

Meeting Abstract

Armand, P.; Shipp, M. A.; Ribrag, V.; Michot, J. M.; Zinzani, P. L.; Gutierrez, M.; Snyder, E.; Ricart, A. D.; Balakumaran, A.; Moskowitz, C. H.
Blood (2015)

Fulltext@MSK | Save

Disruptive ARID1A mutations in follicular lymphoma impair DNA repair efficiency and are associated with favorable outcome in patients receiving first-line immunochemotherapy

Meeting Abstract

Bararia, D.; Heide, M.; Welner, R. S.; Romashova, T.; Pastore, A.; Mathur, R.; Gascoyne, R. D.; Kridel, R.; Willson, B. G.; Roberts, C. W. M.; more...
Blood (2015)

Fulltext@MSK | Save

A chromatin reader that acts as a key to lock in and coordinate recruitment of transcription factors and a novel polycomb complex to bivalent chromatin thus driving formation of germinal centers and B-cell lymphomas

Meeting Abstract

Beguelin, W.; Teater, M.; Corcoran, C.; Hamline, M.; Gascoyne, R. D.; Levine, R. L.; Abdel-Wahab, O.; Shaknovich, R.; Elemento, O.; Bardwell, V. J.; more...
Blood (2015)

Fulltext@MSK | Save